Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05893927
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2023-05-30
Brief Title:
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Sponsor:
The Reading Hospital and Medical Center
Organization:
The Reading Hospital and Medical Center
Study Overview
Official Title:
Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application app that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes and to study the impact of the app on clinical outcomes of diabetes HA1C and educational outcomes Self-Efficacy for Diabetes Scale The main question to answer is Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors BMI and Blood Pressure Patients will be enrolled in one of two available arms of the study
Participants in the intervention arm will use the app to view educational information presented as videos in the following areas Healthy Coping Healthy Eating Staying Active Medications Use and Safety Problem Solving in Diabetes and Disease Pathophysiology They will continue routine follow-up care with their primary care physicians during the study
Participants in the control arm will continue with their primary care physician in routine follow-up care as normally scheduled
Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C systolic blood pressure diastolic blood pressure and body mass index Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale
Participants in the intervention arm will use the app to view educational information presented as videos in the following areas Healthy Coping Healthy Eating Staying Active Medications Use and Safety Problem Solving in Diabetes and Disease Pathophysiology They will continue routine follow-up care with their primary care physicians during the study
Participants in the control arm will continue with their primary care physician in routine follow-up care as normally scheduled
Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C systolic blood pressure diastolic blood pressure and body mass index Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None